These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7916006)

  • 1. Subjective awareness of abnormal involuntary movements in schizophrenia.
    Sandyk R; Kay SR; Awerbuch GI
    Int J Neurosci; 1993; 69(1-4):1-20. PubMed ID: 7916006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia.
    Caligiuri MP; Harris MJ; Jeste DV
    Biol Psychiatry; 1988 Nov; 24(7):787-800. PubMed ID: 2906545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients.
    Brown KW; White T; Palmer D
    Psychol Med; 1992 Feb; 22(1):69-77. PubMed ID: 1349440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
    Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
    Waddington JL; O'Callaghan E; Buckley P; Madigan C; Redmond O; Stack JP; Kinsella A; Larkin C; Ennis JT
    Br J Psychiatry; 1995 Jul; 167(1):41-4. PubMed ID: 7551606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of pineal calcification with drug-induced dystonic movements.
    Sandyk R
    Int J Neurosci; 1990 Aug; 53(2-4):217-22. PubMed ID: 1979970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
    Liddle PF; Barnes TR; Speller J; Kibel D
    Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction.
    Quinn J; Meagher D; Murphy P; Kinsella A; Mullaney J; Waddington JL
    Schizophr Res; 2001 Apr; 49(1-2):79-87. PubMed ID: 11343867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal involuntary movements in patients on long-acting neuroleptics.
    Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia. Patients' lack of awareness of movement disorder.
    Macpherson R; Collis R
    Br J Psychiatry; 1992 Jan; 160():110-2. PubMed ID: 1347479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.
    Gureje O
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1525-30. PubMed ID: 2906088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of the effects of edentulism on the severity rating of tardive dyskinesia.
    Myers DE; Schooler NR; Zullo TG; Levin H
    J Prosthet Dent; 1993 Jun; 69(6):578-81. PubMed ID: 8100580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of two iatrogenic dyskinesias.
    Karson CN; Jeste DV; LeWitt PA; Wyatt RJ
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
    Kulkarni SK; Naidu PS
    Drugs Today (Barc); 2003 Jan; 39(1):19-49. PubMed ID: 12669107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable remission of tardive dyskinesia by L-dopa.
    Ludatscher JI
    J Clin Psychopharmacol; 1989 Feb; 9(1):39-41. PubMed ID: 2565346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.